| Other Names | 819869-77-7, DOTA-tris(tBu)ester NHS ester, Tri-tert-butyl 2, 2', 2''-(10-(2-((2, 5-dioxopyrrolidin-1-yl)oxy)-2-oxoethyl)-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7-triyl)triacetate, DOTA-mono-NHS-tris(t-Bu ester)(B-270), MFCD26131244, tert-butyl 2-[7-[2-(2, 5-dioxopyrrolidin-1-yl)oxy-2-oxoethyl]-4, 10-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1, 4, 7, 10-tetrazacyclododec-1-yl]acetate, [4, 7-Bis-tert-butoxycarbonylmethyl-10-(2, 5-dioxopyrrolidin-1-yloxycarbonylmethyl)-1, 4, 7, 10-tetraazacyclododec-1-yl]-acetic acid tert-butyl ester, DOTA-tris(t-Bu)ester-NHS, SCHEMBL3700587, AKOS030528324, AT26059, BS-51465, DA-63001, SY285850, DOTA tris(tBu)ester NHS ester, HPF6 salt, HY-131326, CS-0133217, A1-08303, [4, 7-Bis-tert-butoxycarbonylmethyl-10-(2, 5-dioxo-pyrrolidin-1-yloxycarbonylmethyl)-1, 4, 7, 10-tetraaza-cyclododec-1-yl]-acetic acid tert-butyl ester, tert-butyl 2-{4, 7-bis[2-(tert-butoxy)-2-oxoethyl]-10-{2-[(2, 5-dioxopyrrolidin-1-yl)oxy]-2-oxoethyl}-1, 4, 7, 10-tetraazacyclododecan-1-yl}acetate, Tri-tert-butyl 2, 2 inverted exclamation mark, 2 inverted exclamation mark inverted exclamation mark -[10-[2-[(2, 5-Dioxopyrrolidin-1-yl)oxy]-2-oxoethyl]-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7-triyl]triacetate, Tri-tert-butyl2, 2', 2''-(10-(2-((2, 5-dioxopyrrolidin-1-yl)oxy)-2-oxoethyl)-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7-triyl)triacetate |
|---|---|
| IUPAC Name | sodium 5-acetyl-4-hydroxy-2-methoxybenzenesulfonate |
| CAS | 849767-19-7 |
| Molecular Weight | 669.8 |
| Molecular Formula | C32H55N5O10 |
| SMILES | CC(C)(C)OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)OC(C)(C)C)CC(=O)ON2C(=O)CCC2=O)CC(=O)OC(C)(C)C |






